Kora Saúde Participações S.A. (BVMF: KRSA3)
Brazil
· Delayed Price · Currency is BRL 7.95
+0.32 (4.19%)
Dec 20, 2024, 6:06 PM GMT-3
Kora Saúde Participações Income Statement
Financials in millions BRL. Fiscal year is January - December.
Millions BRL. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Revenue | 2,276 | 2,260 | 2,047 | 1,262 | 612.29 | 442.04 | Upgrade
|
| Revenue Growth (YoY) | 1.95% | 10.40% | 62.20% | 106.09% | 38.52% | 56.38% | Upgrade
|
| Cost of Revenue | 1,821 | 1,785 | 1,559 | 939.16 | 455.56 | 313.36 | Upgrade
|
| Gross Profit | 455.27 | 474.25 | 487.95 | 322.7 | 156.72 | 128.68 | Upgrade
|
| Selling, General & Admin | 170.49 | 192.81 | 224.67 | 175.48 | 82.59 | 67.09 | Upgrade
|
| Other Operating Expenses | -6.96 | -3.56 | -5.09 | 21.02 | -5.1 | 9.36 | Upgrade
|
| Operating Expenses | 163.53 | 189.25 | 219.59 | 196.5 | 77.5 | 79.89 | Upgrade
|
| Operating Income | 291.74 | 285 | 268.36 | 126.2 | 79.23 | 48.78 | Upgrade
|
| Interest Expense | -337.92 | -345.8 | -302.42 | -106.47 | -52.33 | -38.22 | Upgrade
|
| Interest & Investment Income | 19.84 | 27.06 | 57.84 | 14.62 | 5.52 | 3.66 | Upgrade
|
| Earnings From Equity Investments | 2.45 | 3.92 | 2.62 | 0.84 | -0.1 | 0.02 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | - | 0.08 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | -35.14 | -34.97 | -49.16 | -10.19 | - | -2.08 | Upgrade
|
| EBT Excluding Unusual Items | -59.04 | -64.79 | -22.76 | 25.08 | 32.32 | 12.16 | Upgrade
|
| Legal Settlements | -0.18 | 0.02 | -0.47 | 5.77 | - | -3.16 | Upgrade
|
| Other Unusual Items | -45.04 | -69.21 | -66.49 | -28.02 | - | -0.95 | Upgrade
|
| Pretax Income | -104.26 | -133.99 | -89.72 | 2.83 | 32.32 | 8.05 | Upgrade
|
| Income Tax Expense | -21.98 | 24.08 | 4.75 | 57.79 | 14.78 | 10.38 | Upgrade
|
| Earnings From Continuing Operations | -82.28 | -158.07 | -94.47 | -54.96 | 17.54 | -2.33 | Upgrade
|
| Minority Interest in Earnings | -9.2 | -9.56 | -13.12 | -8.76 | -1.67 | -0.52 | Upgrade
|
| Net Income | -91.49 | -167.62 | -107.59 | -63.72 | 15.87 | -2.84 | Upgrade
|
| Net Income to Common | -91.49 | -167.62 | -107.59 | -63.72 | 15.87 | -2.84 | Upgrade
|
| Shares Outstanding (Basic) | 77 | 77 | 77 | 58 | 40 | 25 | Upgrade
|
| Shares Outstanding (Diluted) | 77 | 77 | 77 | 58 | 40 | 25 | Upgrade
|
| Shares Change (YoY) | 0.05% | 0.32% | 33.80% | 43.75% | 60.96% | -10.66% | Upgrade
|
| EPS (Basic) | -1.18 | -2.17 | -1.40 | -1.11 | 0.40 | -0.11 | Upgrade
|
| EPS (Diluted) | -1.18 | -2.17 | -1.40 | -1.11 | 0.40 | -0.11 | Upgrade
|
| Free Cash Flow | 2.23 | -325.44 | 149 | -83.72 | -13.45 | -64.36 | Upgrade
|
| Free Cash Flow Per Share | 0.03 | -4.21 | 1.93 | -1.45 | -0.34 | -2.58 | Upgrade
|
| Gross Margin | 20.00% | 20.99% | 23.84% | 25.57% | 25.60% | 29.11% | Upgrade
|
| Operating Margin | 12.82% | 12.61% | 13.11% | 10.00% | 12.94% | 11.04% | Upgrade
|
| Profit Margin | -4.02% | -7.42% | -5.26% | -5.05% | 2.59% | -0.64% | Upgrade
|
| Free Cash Flow Margin | 0.10% | -14.40% | 7.28% | -6.63% | -2.20% | -14.56% | Upgrade
|
| EBITDA | 425.34 | 434.02 | 376.62 | 187.13 | 107.22 | 59.53 | Upgrade
|
| EBITDA Margin | 18.68% | 19.21% | 18.40% | 14.83% | 17.51% | 13.47% | Upgrade
|
| D&A For EBITDA | 133.6 | 149.02 | 108.26 | 60.92 | 27.99 | 10.74 | Upgrade
|
| EBIT | 291.74 | 285 | 268.36 | 126.2 | 79.23 | 48.78 | Upgrade
|
| EBIT Margin | 12.82% | 12.61% | 13.11% | 10.00% | 12.94% | 11.04% | Upgrade
|
| Effective Tax Rate | - | - | - | 2039.13% | 45.73% | 128.91% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.